PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3
- PMID: 20609355
- DOI: 10.1016/j.ccr.2010.06.003
PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3
Abstract
As(2)O(3) cures acute promyelocytic leukemia (APL) by initiating PML/RARA oncoprotein degradation, through sumoylation of its PML moiety. However, how As(2)O(3) initiates PML sumoylation has remained largely unexplained. As(2)O(3) binds vicinal cysteines and increases reactive oxygen species (ROS) production. We demonstrate that upon As(2)O(3) exposure, PML undergoes ROS-initiated intermolecular disulfide formation and binds arsenic directly. Disulfide-linked PML or PML/RARA multimers form nuclear matrix-associated nuclear bodies (NBs), become sumoylated and are degraded. Hematopoietic progenitors transformed by an As(2)O(3)-binding PML/RARA mutant exhibit defective As(2)O(3) response. Conversely, nonarsenical oxidants elicit PML/RARA multimerization, NB-association, degradation, and leukemia response in vivo, but do not affect PLZF/RARA-driven APLs. Thus, PML oxidation regulates NB-biogenesis, while oxidation-enforced PML/RARA multimerization and direct arsenic-binding cooperate to enforce APL's exquisite As(2)O(3) sensitivity.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation.Oncotarget. 2015 Sep 22;6(28):25646-59. doi: 10.18632/oncotarget.4662. Oncotarget. 2015. PMID: 26213848 Free PMC article.
-
The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling.Blood. 2012 Jul 26;120(4):847-57. doi: 10.1182/blood-2011-10-388496. Epub 2012 Jun 12. Blood. 2012. PMID: 22692509
-
Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.Science. 2010 Apr 9;328(5975):240-3. doi: 10.1126/science.1183424. Science. 2010. PMID: 20378816
-
Curing APL through PML/RARA degradation by As2O3.Trends Mol Med. 2012 Jan;18(1):36-42. doi: 10.1016/j.molmed.2011.10.001. Epub 2011 Nov 4. Trends Mol Med. 2012. PMID: 22056243 Review.
-
Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology.Curr Pharm Biotechnol. 2013;14(9):849-58. doi: 10.2174/1389201015666140113095812. Curr Pharm Biotechnol. 2013. PMID: 24433507 Review.
Cited by
-
SUMO: Glue or Solvent for Phase-Separated Ribonucleoprotein Complexes and Molecular Condensates?Front Mol Biosci. 2021 May 7;8:673038. doi: 10.3389/fmolb.2021.673038. eCollection 2021. Front Mol Biosci. 2021. PMID: 34026847 Free PMC article. Review.
-
Arsenic trioxide stabilizes accumulations of adeno-associated virus virions at the perinuclear region, increasing transduction in vitro and in vivo.J Virol. 2013 Apr;87(8):4571-83. doi: 10.1128/JVI.03443-12. Epub 2013 Feb 13. J Virol. 2013. PMID: 23408604 Free PMC article.
-
Arsenite inhibits the function of CD133+ CD13+ liver cancer stem cells by reducing PML and Oct4 protein expression.Tumour Biol. 2016 Oct;37(10):14103-14115. doi: 10.1007/s13277-016-5195-7. Epub 2016 Aug 12. Tumour Biol. 2016. PMID: 27517564
-
Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL.Cell Death Differ. 2022 Aug;29(8):1654-1668. doi: 10.1038/s41418-022-00955-8. Epub 2022 Feb 22. Cell Death Differ. 2022. PMID: 35194189 Free PMC article.
-
Protein sumoylation in normal and cancer stem cells.Front Mol Biosci. 2022 Dec 19;9:1095142. doi: 10.3389/fmolb.2022.1095142. eCollection 2022. Front Mol Biosci. 2022. PMID: 36601585 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous